Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Homo sapiens | Oct 01, 2011 | ||||||
GSE23303 |
Gene expression profiling of human atherosclerotic plaque: Laser capture microscopy of smooth muscle cells and macrophages
|
9 | Oscar Puig | Oct 01, 2011 | ||||
GSE23304 |
Gene expression profiling of human atherosclerotic plaque: 101 peripheral plaques
|
109 | Oscar Puig | Oct 01, 2011 | ||||
GSE23314 |
Gene expression profiling of human atherosclerotic plaque
|
521 | Oscar Puig | Oct 01, 2011 | ||||
GSE24450 |
183 breast tumors from the Helsinki Univerisity Central Hospital with survival information
|
183 | Dario Greco | Oct 01, 2011 | ||||
GSE24495 |
Gene expression profiling of human atherosclerotic plaque: Carotid plaque
|
113 | Oscar Puig | Oct 01, 2011 | ||||
GSE24702 |
Gene expression profiling of human atherosclerotic plaque: 290 peripheral plaques
|
290 | Oscar Puig | Oct 01, 2011 | ||||
GSE24787 |
Promoter methylation in HNSCC tumor cell lines is significantly different from primary tumors and xenografts
|
22 | Michael F Ochs | Oct 01, 2011 | ||||
GSE28072 |
Expression data from transfected IB3 cells transfected with CFTR mutants
|
18 | Jerry M. Wright | Oct 01, 2011 | ||||
GSE28858 |
MicroRNA array analysis of platelets in premature coronary artery disease
|
24 | Brigitte Sondermeijer | Oct 01, 2011 | ||||
GSE29106 |
Microarray Profile of Measles Virus Nucleocapsid Protein (MVNP) Regulated Gene Expression in RANKL and M-CSF stimulated normal human bone marrow derived non-adherent cells.
|
2 | Michael Falduto | Oct 01, 2011 | ||||
GSE29107 |
Microarray profile of p62P392L-regulated gene expression in RANKL and M-CSF stimulated normal human bone marrow derived non-adherent cells
|
3 | Michael Falduto | Oct 01, 2011 | ||||
GSE29368 |
CD140a+ human oligodendrocyte progenitor cells
|
10 | Fraser James Sim | Oct 01, 2011 | ||||
GSE30369 |
Gene expression in leucocytes of patients with autosomal dominat neronal ceroid lipofuscinosis (Kufs disease)
|
8 | Viktor Stranecky | Oct 01, 2011 | ||||
GSE31421 |
Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide [expression profiling]
|
15 | Esteban Braggio | Oct 01, 2011 | ||||
GSE31451 |
Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide [aCGH]
|
2 | Esteban Braggio | Oct 01, 2011 | ||||
GSE31452 |
Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide
|
17 | Esteban Braggio | Oct 01, 2011 | ||||
GSE32301 |
Expression profiling of RBM38-knocked down and control MCF7 cells with and without doxorubicin treatment
|
8 | Ran Elkon | Oct 01, 2011 | ||||
GSE32441 |
TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in human fibrosarcoma cells.
|
13 | Kamran Harati | Oct 01, 2011 | ||||
GSE32482 |
Gene expression profiles of Glioblastoma stem cells in which ALK or pleiotrophin expression was suppressed.
|
3 | Tetsu Akiyama | Oct 01, 2011 | ||||
GSE32507 |
Expression profile of carcinosarcoma (CS), endometrioid adenocarcinoma (EC) and sarcoma (US) of uterine corpus
|
46 | Tatsuyuki Chiyoda | Oct 01, 2011 |